Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights

Gastric cancer is a significant global health problem as it is the fifth most prevalent cancer worldwide and the fourth leading cause of cancer-related mortality. While cytotoxic chemotherapy remains the primary treatment for advanced GC, response rates are limited. Recent progresses, focused on mol...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatterjee, Annesha, Azevedo-Martins, Jordana Maria, Stachler, Matthew D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424681/
https://www.ncbi.nlm.nih.gov/pubmed/37583706
http://dx.doi.org/10.2147/OTT.S389120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424681/
https://www.ncbi.nlm.nih.gov/pubmed/37583706
http://dx.doi.org/10.2147/OTT.S389120

Ejemplares similares